Raphael Pharmaceutical Inc.
RAPH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$429 | – | – |
| Dep. & Amort. | – | $0 | – | – |
| Deferred Tax | – | $0 | – | – |
| Stock-Based Comp. | – | $197 | – | – |
| Change in WC | – | $23 | – | – |
| Other Non-Cash | – | $0 | – | – |
| Operating Cash Flow | – | -$209 | – | – |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | – | – |
| Net Acquisitions | – | $0 | – | – |
| Inv. Purchases | – | $0 | – | – |
| Inv. Sales/Matur. | – | $0 | – | – |
| Other Inv. Act. | – | $0 | – | – |
| Investing Cash Flow | – | $0 | – | – |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | – | – |
| Stock Issued | – | $240 | – | – |
| Stock Repurch. | – | $0 | – | – |
| Dividends Paid | – | $0 | – | – |
| Other Fin. Act. | – | $0 | – | – |
| Financing Cash Flow | – | $240 | – | – |
| Forex Effect | – | $0 | – | – |
| Net Chg. in Cash | – | $31 | – | – |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $19 | – | – |
| End Cash | – | $50 | – | – |
| Free Cash Flow | – | -$209 | – | – |